Home/Genoscience Pharma/Philippe Halfon
PH

Philippe Halfon

CEO

Genoscience Pharma

Therapeutic Areas

Genoscience Pharma Pipeline

DrugIndicationPhase
GNS561Primary Liver Cancers (e.g., Hepatocellular Carcinoma)Phase 2
Gento-Fibrose Pulmonaire ProgramIdiopathic Pulmonary Fibrosis (IPF)Preclinical